Cost-effectiveness of remdesivir for the treatment of hospitalized patients with COVID-19: a systematic review.

ABSTRACT:

Background

Remdesivir is being studied and used to treat coronavirus disease 2019 (COVID-19). This study aimed to systematically identify, critically evaluate, and summarize the findings of the studies on the cost-effectiveness of remdesivir in the treatment of hospitalized patients with COVID-19.

Methods

In this systematic review, PubMed, EMBASE, Web of Science, SCOPUS, and the Cochrane Library were searched for studies published between 2019 and 2022. We included all full economic evaluations of remdesivir for the treatment of hospitalized patients with COVID-19. Data were summarized in a structured and narrative manner.

Results

Out of 616 articles obtained in this literature search, 12 studies were included in the final analysis. The mean score of the Quality of He

SUBMITTER: Rezapour A 

PROVIDER: S-EPMC10116457 | biostudies-literature | 2023 Apr

REPOSITORIES: biostudies-literature